Biotech Innovent Receives Second Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Squamous Non-Small Cell Lung Cancer February 18, 2025
Biotech DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development February 13, 2025
Biotech Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025 February 12, 2025
Biotech Bio X Cell Expands Global Reach with New Distribution Center in Beijing, China February 11, 2025
Biotech Fapon at Medlab Middle East 2025: Advancing Local Diagnostic Industry through One-stop IVD Solutions February 3, 2025
Biotech AMGEN ANNOUNCES WEBCAST OF 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS February 2, 2025
Biotech Human Organs-on-Chips Market to Reach USD 1019 Million by 2031 | 31.2% CAGR Growth Forecast – Valuates Reports February 1, 2025
Biotech Zymo Research Launches Microbiome Grant to Support Innovation in Microbial Sciences January 30, 2025
Biotech Taiho Pharmaceutical, Taiho Oncology, and Cullinan Therapeutics Announce Primary Endpoint Met in Phase 2b Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy January 29, 2025